Stay updated on ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page shows a new revision tag (v3.6.6) indicating a new build or patch, but the study details and visible content remain unchanged.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page now includes the full study details with attached documents (Study Protocol and Statistical Analysis Plan) and expanded metadata. The previous error page content has been removed, restoring access to the study record.SummaryDifference41%

- Check38 days agoChange DetectedThe revision label on the page updated from v3.6.4 to v3.6.5, indicating a newer build of the site template and assets.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page displays Revision: v3.6.4, replacing the previous v3.6.3, signaling a platform update to the site interface.SummaryDifference0.1%

- Check73 days agoChange DetectedThe revision label was updated from v3.6.2 to v3.6.3, indicating a maintenance release rather than substantive changes to study information.SummaryDifference0.1%

- Check81 days agoChange DetectedThe page revision metadata was updated from v3.6.0 to v3.6.2, indicating a newer version of the page. No study details or user-facing content appear to be altered.SummaryDifference0.1%

Stay in the know with updates to ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACP-196 and Pembrolizumab in Pancreatic Cancer Clinical Trial page.